Better Stem Cell Tx Outcomes for Younger MS Patients

Share this content:
Better Stem Cell Tx Outcomes for Younger MS Patients
Better Stem Cell Tx Outcomes for Younger MS Patients

MONDAY, Feb. 20, 2017 (HealthDay News) -- Stem cell transplants may halt the progression of aggressive multiple sclerosis (MS) in nearly half of those with the disease, but selecting the right patients for the treatment is key, according to a study published online Feb. 20 in JAMA Neurology.

Riccardo Saccardi, M.D., from the cell therapy and transfusion medicine unit at Careggi University Hospital in Florence, Italy, and colleagues followed 281 patients with predominantly progressive forms of MS. The patients were from 13 countries and all had undergone autologous hematopoietic stem cell transplant between 1995 and 2006.

The researchers found that 46 percent of the patients experienced progression-free survival at five years after transplant. Younger patients with a relapsing form of MS who were not severely disabled and who hadn't found relief with other treatments fared better than others over five years. Within 100 days of transplant, eight patients died (2.8 percent). The researchers believe these deaths were most likely due to the transplant technology used before 2006, which has since improved.

"Stem cell transplantation cannot be considered a cure for MS," Saccardi told HealthDay. "However, it can be considered a concrete option for patients showing aggressive MS who have not responded to approved treatments."

More than one author disclosed financial ties to pharmaceutical and biotechnology companies, several of which contributed funding for the study.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Hospitals Vary Widely in Moving Stroke Patients to Comfort Care

Hospitals Vary Widely in Moving Stroke Patients to ...

Doctors more apt to suggest it sooner for older, white, female, and uninsured patients

Peri-Op IV Acetaminophen May Reduce Post-Op Pain in Sinus Sx

Peri-Op IV Acetaminophen May Reduce Post-Op Pain in ...

Reduction in immediate postoperative pain after endoscopic sinus surgery, but results inconclusive

Location of Body Fat Can Indicate Obesity-Related Cancer Risk

Location of Body Fat Can Indicate Obesity-Related Cancer ...

Where fat is carried is as strong a predictor as BMI, researchers suggest

is free, fast, and customized just for you!

Already a member?

Sign In Now »